세계의 창상관리 시장 규모, 점유율, 동향 분석 리포트 : 제품별, 용도별, 최종 용도별, 구입 형태별, 유통 채널별, 지역별, 부문별 예측(2025-2030년)

Wound Care Market Size, Share & Trends Analysis Report By Product (Advanced Wound Dressing, Surgical Wound Care), By Application (Chronic, Acute), By End-use, By Mode Of Purchase, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,443,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,862,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,700,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

창상관리 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 리포트에 따르면 세계의 창상관리 시장 규모는 2025-2030년에 CAGR 4.19%로 성장하며, 2030년에는 295억 7,000만 달러에 달할 것으로 예측됩니다.

수술 건수 증가, 급속한 고령화, 당뇨병 환자 증가 등이 이 시장의 성장을 가속하는 주요 요인입니다. 예를 들어 Aging Asia에 따르면 2019년 현재 인도 전체 인구의 약 10%인 1억 3,900만 명 이상이 60세 이상입니다. 이는 2050년에는 19.5%까지 증가할 것으로 예상됩니다. 노인 인구는 상처에 걸리기 쉽기 때문에 노인 인구 증가는 예측 기간 중 상처 관리 시장을 촉진할 것으로 예상됩니다.

상처 치료 시장은 최근 기술 발전으로 인해 다양한 유형의 상처를 치료할 수 있는 새롭고 혁신적인 제품들이 개발되고 있습니다. 성장인자는 세포의 성장과 분열을 자극하는 천연 유래 단백질입니다. 이러한 단백질은 상처 치료에 사용되어 치유와 조직 재생을 촉진할 수 있습니다. 예를 들어 혈소판 유래 성장인자(PDGF)는 만성 상처의 치유를 촉진하는 데 효과적이며, 3D 프린팅 기술은 의족, 보조기, 상처 드레싱 등 맞춤형 상처 치료 제품의 제조에 혁명을 일으켰습니다.

또한 많은 주요 제조업체들이 제품 출시, 제휴, 지역적 확장 등의 전략적 노력을 기울이고 있으며, 이는 예측 기간 중 상처 관리 제품에 대한 수요 증가를 포착하는 데 도움이 될 것으로 보입니다. 예를 들어 Human Biosciences는 인도 시장에서 두 가지 새로운 상처 치료 제품을 출시할 계획입니다. 이 제품들을 인도 시장에 출시함으로써 이 회사는 팬데믹 이후 인도 상처 관리 시장을 선점할 수 있을 것으로 보입니다. 이와 같이 다른 시장 진출기업의 유사한 노력은 팬데믹 이후 상처 관리 시장을 촉진할 것으로 예상됩니다.

상처 관리 시장 보고서의 하이라이트

• 제품별로는 첨단 상처 드레싱이 기존 드레싱에 비해 장점이 있으며, 2024년 34.9%의 점유율을 차지하며 상처 치료 시장을 장악했습니다.
• 용도별로는 당뇨병성 족부 궤양과 욕창 증가로 인해 만성 상처 부문이 2024년 59.9%의 점유율을 차지하며 상처 관리 시장을 장악할 가능성이 높습니다.
• 최종 용도별로는 병원 부문이 입원 환자의 수술 부위 감염이 증가함에 따라 병원 부문이 상처 관리 시장을 주도하고 있습니다. 반면, 재택치료 부문은 예측 기간 중 가장 빠른 성장세를 보일 것으로 예상됩니다.
• 구매 형태별로는 처방전 부문이 2024년 62.8%의 점유율로 상처 관리 시장을 장악했습니다.
• 유통 채널별로는 기관 판매 부문이 시장을 주도하고 있습니다. 그러나 예측 기간 중 4.6%의 연평균 복합 성장률(CAGR)로 소매 판매 부문이 가장 빠르게 성장할 것으로 예상됩니다.
• 북미는 외과수술 증가와 기술 발전으로 2024년 45.5%의 가장 높은 매출 점유율을 차지하며 상처 관리 시장을 장악했습니다.

목차

제1장 조사 방법과 범위

제2장 개요

제3장 창상관리 시장의 변수, 동향, 범위

• 시장 계통 전망
  • 모시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
  • 시장 기회 분석
  • 시장이 해결해야 할 과제 분석
• 창상관리 시장 분석 툴
  • 업계 분석 : Porter의 산업 분석
  • PESTEL 분석

제4장 창상관리 시장 : 제품 추정·동향 분석

• 부문 대시보드
• 세계의 창상관리 시장 변동 분석
• 세계의 창상관리 시장 규모와 동향 분석 : 제품별(2018-2030년)
• 첨단 창상 피복재
  • 폼 피복재
  • 하이드로콜로이드 피복재
  • 필름 피복재
  • 알긴산피복재
  • 하이드로겔 피복재
  • 콜라겐 피복재
  • 기타 첨단 피복재
• 외과적 창상관리
  • 봉합사와 스테이플
  • 조직 접착제 및 실란트
  • 항감염성 피복재
• 기존 창상관리
  • 의료용 테이프
  • 코튼
  • 붕대
  • 거즈
  • 스펀지
  • 세정제
• 창상 치료 기기
  • 음압폐쇄 요법
  • 산소 및 고압 산소 장비
  • 전기 자극 기기
  • 압력 완화 기기
  • 기타

제5장 창상관리 시장 : 용도 추정·동향 분석

• 부문 대시보드
• 세계의 창상관리 시장 변동 분석
• 세계의 창상관리 시장 규모와 동향 분석 : 용도별(2018-2030년)
• 급성 창상
  • 외과수술 및 외상
  • 화상
• 만성 창상
  • 당뇨병성 족궤양
  • 욕창
  • 정맥성 하지 궤양
  • 기타 만성 창상

제6장 창상관리 시장 : 최종 용도 추정·동향 분석

• 부문 대시보드
• 세계의 창상관리 시장 변동 분석
• 세계의 창상관리 시장 규모와 동향 분석 : 최종 용도별(2018-2030년)
• 병원
  • 병원 시장 추산·예측(2018-2030년)
• 전문 클리닉
  • 전문 클리닉 시장 추산·예측(2018-2030년)
• 재택 헬스케어
  • 재택 헬스케어 시장 추산·예측(2018-2030년)
• 의사 오피스
  • 의사 오피스 시장 추산·예측(2018-2030년)
• 요양시설
  • 요양시설 시장 추산·예측(2018-2030년)
• 기타
  • 기타 시장 추산·예측(2018-2030년)

제7장 창상관리 시장 : 구입 형태 추정·동향 분석

• 부문 대시보드
• 세계의 창상관리 시장 변동 분석
• 세계의 창상관리 시장 규모와 동향 분석 : 구입 형태별(2018-2030년)
• 처방전
• 비처방전(OTC)

제8장 창상관리 시장 : 유통 채널 추정·동향 분석

• 부문 대시보드
• 세계의 창상관리 시장 변동 분석
• 세계의 창상관리 시장 규모와 동향 분석 : 유통 채널별(2018-2030년)
• 기관용 판매
• 소매 판매

제9장 창상관리 시장 : 지역 추정·동향 분석

• 지역 대시보드
• 시장 규모와 예측 및 동향 분석(2018-2030년)
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 인도
  • 중국
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제10장 경쟁 구도

• 시장 참여 기업의 분류
• 주요 기업 개요
  • Smith+Nephew
  • Convatec Group PLC,
  • Molnlycke Health Care AB
  • Baxter
  • DeRoyal Industries, Inc
  • Coloplast Corp.
  • Medtronic
  • 3M
  • INTEGRA LIFESCIENCES
  • Medline Industries, LP
  • Johnson &Johnson Services, Inc.
  • B. Braun SE
  • Cardinal Health
  • Organogenesis Inc
  • MIMEDX Group, Inc.
• 히트맵 분석/기업 시장 현황 분석
• 2024년 기업 시장 점유율 추정 분석
• 기타 주요 시장 기업의 리스트

KSA

영문 목차

영문목차

Wound Care Market Growth & Trends:

The global wound care market is anticipated to reach USD 29.57 billion by 2030, growing at a CAGR of 4.19% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing number of surgical cases, a rapidly aging population, as well as a rising number of diabetic patients, are among the major factors driving this market's growth. For instance, according to Ageing Asia, as of 2019, more than 139 million people, i.e., about 10% of India's total population, were over 60. This is expected to increase up to 19.5% in 2050. The geriatric population is more susceptible to wounds, and thus, increasing the number of elder populations, the wound care market is anticipated to propel during the forecast period.

The wound care market has seen significant technological advancements in recent years, leading to the development of new and innovative products for treating various types of wounds. Growth factors are naturally occurring proteins that stimulate cell growth and division. These proteins can be used in wound care to promote healing and tissue regeneration. For example, platelet-derived growth factor (PDGF) is effective in promoting the healing of chronic wounds. 3D printing technology has revolutionized the production of custom-made wound care products, such as prosthetic limbs, orthotics, and wound dressings.

In addition, many leading manufacturers are undergoing strategic initiatives such as product launches, partnerships, and geographic expansion, which may help them capitalize on the increasing demand for wound care products during the forecast period. For instance, Human Biosciences planned on launching two new wound care products in the Indian market. The launch of these products in the Indian market is expected to help the company capture the post-pandemic wound care market in India. Thus, similar initiatives by other market players are anticipated to boost the wound care market post-pandemic.

Wound Care Market Report Highlights:

• Based on product, advanced wound dressing dominated the wound care market with a share of 34.9% in 2024, owing to the advantages offered by these dressings over traditional.
• Based on application, the chronic wound segment will likely dominate the wound care market with a market share of 59.9% in 2024, owing to increased diabetic foot ulcers and pressure ulcers worldwide.
• Based on end-use, the hospital segment dominated the wound care market, owing to the increasing number of surgical site infections among hospital patients. On the other hand, the home healthcare segment is anticipated to witness the fastest growth in the forecast period.
• Based on the mode of purchase, the prescribed segment dominated the wound care market, with a share of 62.8% in 2024.
• Based on the distribution channel, the institutional sales segment dominated the market. However, the retail sales segment is anticipated to witness the fastest growth, with a CAGR of 4.6% over the forecast period.
• North America dominated the wound care market with the highest revenue share of 45.5% in 2024 owing to the increasing number of surgical procedures and technological advancements.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Wound Care Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing prevalence of chronic diseases and conditions affecting wound healing capabilities
    • 3.2.1.2. Rising incidence of burn injuries
    • 3.2.1.3. Introduction of innovative and advanced wound products
    • 3.2.1.4. Rising geriatric population
    • 3.2.1.5. Increasing number of road accidents and trauma injuries
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of advanced wound care products and chronic wound treatments
    • 3.2.2.2. Delayed diagnosis and lower treatment rates in emerging nations
  • 3.2.3. Market opportunity analysis
    • 3.2.3.1. Improvements in public and private hospital infrastructure
    • 3.2.3.2. Growth potential in emerging economies in wound care market
    • 3.2.3.3. Rising number of clinical trials
  • 3.2.4. Market challenge analysis
    • 3.2.4.1. Growing number of product recalls
    • 3.2.4.2. Lack of awareness about proper wound care practices and available treatment options
• 3.3. Wound Care Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. Wound Care Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Wound Care Market Movement Analysis
• 4.3. Global Wound Care Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Advanced wound dressing
  • 4.4.1. Advanced wound dressing market estimates and forecast 2018 to 2030 (USD Million)
  • 4.4.2. Foam dressings
    • 4.4.2.1. Foam dressings market estimates and forecast 2018 to 2030 (USD Million)
  • 4.4.3. Hydrocolloid dressings
    • 4.4.3.1. Hydrocolloid dressings market estimates and forecast 2018 to 2030 (USD Million)
  • 4.4.4. Film dressings
    • 4.4.4.1. Film dressings market estimates and forecast 2018 to 2030 (USD Million)
  • 4.4.5. Alginate dressings
    • 4.4.5.1. Alginate dressings market estimates and forecast 2018 to 2030 (USD Million)
  • 4.4.6. Hydrogel dressings
    • 4.4.6.1. Hydrogel dressings market estimates and forecast 2018 to 2030 (USD Million)
  • 4.4.7. Collagen dressings
    • 4.4.7.1. Collagen dressings market estimates and forecast 2018 to 2030 (USD Million)
  • 4.4.8. Other advanced dressings
    • 4.4.8.1. Other advanced dressings market estimates and forecast 2018 to 2030 (USD Million)
• 4.5. Surgical wound care
  • 4.5.1. Surgical wound care market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.2. Sutures & staples
    • 4.5.2.1. Sutures & staples market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.3. Tissue adhesives & sealants
    • 4.5.3.1. Tissue adhesives & sealants market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.4. Anti-infective dressing
    • 4.5.4.1. Anti-infective dressing market estimates and forecast 2018 to 2030 (USD Million)
• 4.6. Traditional wound care
  • 4.6.1. Traditional wound care market estimates and forecast 2018 to 2030 (USD Million)
  • 4.6.2. Medical tapes
    • 4.6.2.1. Medical tapes market estimates and forecast 2018 to 2030 (USD Million)
  • 4.6.3. Cotton
    • 4.6.3.1. Cotton market estimates and forecast 2018 to 2030 (USD Million)
  • 4.6.4. Bandages
    • 4.6.4.1. Bandages market estimates and forecast 2018 to 2030 (USD Million)
  • 4.6.5. Gauzes
    • 4.6.5.1. Gauzes market estimates and forecast 2018 to 2030 (USD Million)
  • 4.6.6. Sponges
    • 4.6.6.1. Sponges market estimates and forecast 2018 to 2030 (USD Million)
  • 4.6.7. Cleansing agents
    • 4.6.7.1. Cleansing agents market estimates and forecast 2018 to 2030 (USD Million)
• 4.7. Wound therapy devices
  • 4.7.1. Wound therapy devices market estimates and forecast 2018 to 2030s (USD Million)
  • 4.7.2. Negative pressure wound therapy
    • 4.7.2.1. Negative pressure wound therapy market estimates and forecast 2018 to 2030 (USD Million)
  • 4.7.3. Oxygen and hyperbaric oxygen equipment
    • 4.7.3.1. Oxygen and hyperbaric oxygen equipment market estimates and forecast 2018 to 2030 (USD Million)
  • 4.7.4. Electric stimulation devices
    • 4.7.4.1. Electric stimulation devices market estimates and forecast 2018 to 2030 (USD Million)
  • 4.7.5. Pressure relief devices
    • 4.7.5.1. Pressure relief devices market estimates and forecast 2018 to 2030 (USD Million)
  • 4.7.6. Others
    • 4.7.6.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Wound Care Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Wound Care Market Movement Analysis
• 5.3. Global Wound Care Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Acute Wounds
  • 5.4.1. Acute wounds market estimates and forecast 2018 to 2030 (USD Million)
  • 5.4.2. Surgical & traumatic wounds
    • 5.4.2.1. Surgical & traumatic wounds market estimates and forecast 2018 to 2030 (USD Million)
  • 5.4.3. Burns
    • 5.4.3.1. Burns market estimates and forecast 2018 to 2030 (USD Million)
• 5.5. Chronic Wounds
  • 5.5.1. Chronic wounds market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.2. Diabetic foot ulcers
    • 5.5.2.1. Diabetic foot ulcers market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.3. Pressure ulcers
    • 5.5.3.1. Pressure ulcers market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.4. Venous leg ulcers
    • 5.5.4.1. Venous leg ulcers market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.5. Others chronic wounds
    • 5.5.5.1. Others chronic wounds market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Wound Care Devices: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Wound Care Market Movement Analysis
• 6.3. Global Wound Care Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
• 6.5. Specialty clinics
  • 6.5.1. Specialty clinics centers market estimates and forecast 2018 to 2030 (USD Million)
• 6.6. Home healthcare
  • 6.6.1. Home healthcare market estimates and forecast 2018 to 2030 (USD Million)
• 6.7. Physician's office
  • 6.7.1. Physician's office market estimates and forecast 2018 to 2030 (USD Million)
• 6.8. Nursing Homes
  • 6.8.1. Nursing homes market estimates and forecast 2018 to 2030 (USD Million)
• 6.9. Others
  • 6.9.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Wound Care Market: Mode of Purchase Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Wound Care Market Movement Analysis
• 7.3. Global Wound Care Market Size & Trend Analysis, by Mode Of Purchase, 2018 to 2030 (USD Million)
• 7.4. Prescribed
  • 7.4.1. Prescribed market estimates and forecast 2018 to 2030 (USD Million)
• 7.5. Non-prescribed (OTC)
  • 7.5.1. Non-prescribed (OTC) market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. Wound Care Market: Distribution Channel Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Global Wound Care Market Movement Analysis
• 8.3. Global Wound Care Market Size & Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
• 8.4. Institutional sales
  • 8.4.1. Institutional sales market estimates and forecast 2018 to 2030 (USD Million)
• 8.5. Retail sales
  • 8.5.1. Retail sales market estimates and forecast 2018 to 2030 (USD Million)

Chapter 9. Wound Care Market: Regional Estimates & Trend Analysis

• 9.1. Regional Dashboard
• 9.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
• 9.3. North America
  • 9.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 9.3.2. U.S.
    • 9.3.2.1. Key country dynamics
    • 9.3.2.2. Competitive scenario
    • 9.3.2.3. Regulatory framework
    • 9.3.2.4. Reimbursement scenario
    • 9.3.2.5. U.S. market estimates and forecasts, 2018 - 2030
  • 9.3.3. Canada
    • 9.3.3.1. Key country dynamics
    • 9.3.3.2. Competitive scenario
    • 9.3.3.3. Regulatory framework
    • 9.3.3.4. Reimbursement scenario
    • 9.3.3.5. Canada market estimates and forecasts, 2018 - 2030
  • 9.3.4. Mexico
    • 9.3.4.1. Key country dynamics
    • 9.3.4.2. Competitive scenario
    • 9.3.4.3. Regulatory framework
    • 9.3.4.4. Reimbursement scenario
    • 9.3.4.5. Mexico market estimates and forecasts, 2018 - 2030
• 9.4. Europe
  • 9.4.1. UK
    • 9.4.1.1. Key country dynamics
    • 9.4.1.2. Competitive scenario
    • 9.4.1.3. Regulatory framework
    • 9.4.1.4. Reimbursement scenario
    • 9.4.1.5. UK market estimates and forecasts, 2018 - 2030
  • 9.4.2. Germany
    • 9.4.2.1. Key country dynamics
    • 9.4.2.2. Competitive scenario
    • 9.4.2.3. Regulatory framework
    • 9.4.2.4. Reimbursement scenario
    • 9.4.2.5. Germany market estimates and forecasts, 2018 - 2030
  • 9.4.3. France
    • 9.4.3.1. Key country dynamics
    • 9.4.3.2. Competitive scenario
    • 9.4.3.3. Regulatory framework
    • 9.4.3.4. Reimbursement scenario
    • 9.4.3.5. France market estimates and forecasts, 2018 - 2030
  • 9.4.4. Italy
    • 9.4.4.1. Key country dynamics
    • 9.4.4.2. Competitive scenario
    • 9.4.4.3. Regulatory framework
    • 9.4.4.4. Reimbursement scenario
    • 9.4.4.5. Italy market estimates and forecasts, 2018 - 2030
  • 9.4.5. Spain
    • 9.4.5.1. Key country dynamics
    • 9.4.5.2. Competitive scenario
    • 9.4.5.3. Regulatory framework
    • 9.4.5.4. Reimbursement scenario
    • 9.4.5.5. Spain market estimates and forecasts, 2018 - 2030
  • 9.4.6. Denmark
    • 9.4.6.1. Key country dynamics
    • 9.4.6.2. Competitive scenario
    • 9.4.6.3. Regulatory framework
    • 9.4.6.4. Reimbursement scenario
    • 9.4.6.5. Denmark market estimates and forecasts, 2018 - 2030
  • 9.4.7. Sweden
    • 9.4.7.1. Key country dynamics
    • 9.4.7.2. Competitive scenario
    • 9.4.7.3. Regulatory framework
    • 9.4.7.4. Reimbursement scenario
    • 9.4.7.5. Sweden market estimates and forecasts, 2018 - 2030
  • 9.4.8. Norway
    • 9.4.8.1. Key country dynamics
    • 9.4.8.2. Competitive scenario
    • 9.4.8.3. Regulatory framework
    • 9.4.8.4. Reimbursement scenario
    • 9.4.8.5. Norway market estimates and forecasts, 2018 - 2030
• 9.5. Asia Pacific
  • 9.5.1. Japan
    • 9.5.1.1. Key country dynamics
    • 9.5.1.2. Competitive scenario
    • 9.5.1.3. Regulatory framework
    • 9.5.1.4. Reimbursement scenario
    • 9.5.1.5. Japan market estimates and forecasts, 2018 - 2030
  • 9.5.2. India
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. Competitive scenario
    • 9.5.2.3. Regulatory framework
    • 9.5.2.4. Reimbursement scenario
    • 9.5.2.5. India market estimates and forecasts, 2018 - 2030
  • 9.5.3. China
    • 9.5.3.1. Key country dynamics
    • 9.5.3.2. Competitive scenario
    • 9.5.3.3. Regulatory framework
    • 9.5.3.4. Reimbursement scenario
    • 9.5.3.5. China market estimates and forecasts, 2018 - 2030
  • 9.5.4. South Korea
    • 9.5.4.1. Key country dynamics
    • 9.5.4.2. Competitive scenario
    • 9.5.4.3. Regulatory framework
    • 9.5.4.4. Reimbursement scenario
    • 9.5.4.5. South Korea market estimates and forecasts, 2018 - 2030
  • 9.5.5. Australia
    • 9.5.5.1. Key country dynamics
    • 9.5.5.2. Competitive scenario
    • 9.5.5.3. Regulatory framework
    • 9.5.5.4. Reimbursement scenario
    • 9.5.5.5. Australia market estimates and forecasts, 2018 - 2030
  • 9.5.6. Thailand
    • 9.5.6.1. Key country dynamics
    • 9.5.6.2. Competitive scenario
    • 9.5.6.3. Regulatory framework
    • 9.5.6.4. Reimbursement scenario
    • 9.5.6.5. Thailand market estimates and forecasts, 2018 - 2030
• 9.6. Latin America
  • 9.6.1. Brazil
    • 9.6.1.1. Key country dynamics
    • 9.6.1.2. Competitive scenario
    • 9.6.1.3. Regulatory framework
    • 9.6.1.4. Reimbursement scenario
    • 9.6.1.5. Brazil market estimates and forecasts, 2018 - 2030
  • 9.6.2. Argentina
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Competitive scenario
    • 9.6.2.3. Regulatory framework
    • 9.6.2.4. Reimbursement scenario
    • 9.6.2.5. Argentina market estimates and forecasts, 2018 - 2030
• 9.7. MEA
  • 9.7.1. South Africa
    • 9.7.1.1. Key country dynamics
    • 9.7.1.2. Competitive scenario
    • 9.7.1.3. Regulatory framework
    • 9.7.1.4. Reimbursement scenario
    • 9.7.1.5. South Africa market estimates and forecasts, 2018 - 2030
  • 9.7.2. Saudi Arabia
    • 9.7.2.1. Key country dynamics
    • 9.7.2.2. Competitive scenario
    • 9.7.2.3. Regulatory framework
    • 9.7.2.4. Reimbursement scenario
    • 9.7.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
  • 9.7.3. UAE
    • 9.7.3.1. Key country dynamics
    • 9.7.3.2. Competitive scenario
    • 9.7.3.3. Regulatory framework
    • 9.7.3.4. Reimbursement scenario
    • 9.7.3.5. UAE market estimates and forecasts, 2018 - 2030
  • 9.7.4. Kuwait
    • 9.7.4.1. Key country dynamics
    • 9.7.4.2. Competitive scenario
    • 9.7.4.3. Regulatory framework
    • 9.7.4.4. Reimbursement scenario
    • 9.7.4.5. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 10. Competitive Landscape

• 10.1. Market Participant Categorization
• 10.2. Key Company Profiles
  • 10.2.1. Smith+Nephew
    • 10.2.1.1. Company overview
    • 10.2.1.2. Financial performance
    • 10.2.1.3. Product benchmarking
    • 10.2.1.4. Strategic initiatives
  • 10.2.2. Convatec Group PLC,
    • 10.2.2.1. Company overview
    • 10.2.2.2. Financial performance
    • 10.2.2.3. Product benchmarking
    • 10.2.2.4. Strategic initiatives
  • 10.2.3. Molnlycke Health Care AB
    • 10.2.3.1. Company overview
    • 10.2.3.2. Financial performance
    • 10.2.3.3. Product benchmarking
    • 10.2.3.4. Strategic initiatives
  • 10.2.4. Baxter
    • 10.2.4.1. Company overview
    • 10.2.4.2. Financial performance
    • 10.2.4.3. Product benchmarking
    • 10.2.4.4. Strategic initiatives
  • 10.2.5. DeRoyal Industries, Inc
    • 10.2.5.1. Company overview
    • 10.2.5.2. Financial performance
    • 10.2.5.3. Product benchmarking
    • 10.2.5.4. Strategic initiatives
  • 10.2.6. Coloplast Corp.
    • 10.2.6.1. Company overview
    • 10.2.6.2. Financial performance
    • 10.2.6.3. Product benchmarking
    • 10.2.6.4. Strategic initiatives
  • 10.2.7. Medtronic
    • 10.2.7.1. Company overview
    • 10.2.7.2. Financial performance
    • 10.2.7.3. Product benchmarking
    • 10.2.7.4. Strategic initiatives
  • 10.2.8. 3M
    • 10.2.8.1. Company overview
    • 10.2.8.2. Financial performance
    • 10.2.8.3. Product benchmarking
    • 10.2.8.4. Strategic initiatives
  • 10.2.9. INTEGRA LIFESCIENCES
    • 10.2.9.1. Company overview
    • 10.2.9.2. Financial performance
    • 10.2.9.3. Product benchmarking
    • 10.2.9.4. Strategic initiatives
  • 10.2.10. Medline Industries, LP
    • 10.2.10.1. Company overview
    • 10.2.10.2. Financial performance
    • 10.2.10.3. Product benchmarking
    • 10.2.10.4. Strategic initiatives
  • 10.2.11. Johnson & Johnson Services, Inc.
    • 10.2.11.1. Company overview
    • 10.2.11.2. Financial performance
    • 10.2.11.3. Product benchmarking
    • 10.2.11.4. Strategic initiatives
  • 10.2.12. B. Braun SE
    • 10.2.12.1. Company overview
    • 10.2.12.2. Financial performance
    • 10.2.12.3. Product benchmarking
    • 10.2.12.4. Strategic initiatives
  • 10.2.13. Cardinal Health
    • 10.2.13.1. Company overview
    • 10.2.13.2. Financial performance
    • 10.2.13.3. Product benchmarking
    • 10.2.13.4. Strategic initiatives
  • 10.2.14. Organogenesis Inc
    • 10.2.14.1. Company overview
    • 10.2.14.2. Financial performance
    • 10.2.14.3. Product benchmarking
    • 10.2.14.4. Strategic initiatives
  • 10.2.15. MIMEDX Group, Inc.
    • 10.2.15.1. Company overview
    • 10.2.15.2. Financial performance
    • 10.2.15.3. Product benchmarking
    • 10.2.15.4. Strategic initiatives
• 10.3. Heat Map Analysis/ Company Market Position Analysis
• 10.4. Estimated Company Market Share Analysis, 2024
• 10.5. List of Other Key Market Players

관련자료